Form4insider filings, from the source

SEC Form 4 · accession 0001192482-16-000553

COLLEGIUM PHARMACEUTICAL, INC · COLL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Thomas Heffernan
Officer — Chairman, President and CEO · Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 5, 2016M9,673$3.31A383,117D
Common StockApr 5, 2016M3,931$0.48A387,048D
Common StockF1holding———163,043IBy: Island View Investors, LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Purchase)F2$3.31Apr 5, 2016M9,673D—Nov 11, 2020Common Stock9,6730D
Stock Option (Right to Purchase)F3$0.48Apr 5, 2016M3,931D—Jan 30, 2023Common Stock3,9313,013D

Explanation of responses